FDA Milestone
FDA Milestone. Approval of brentuximab vedotin for sale and marketing by the FDA
Found in
SEATTLE GENETICS INC contract
FDA Milestone. The first approval by the FDA for the commercial sale and marketing of SGN-CD33A in the United States by the Company, any Subsidiary or any Partner
Found in
SEATTLE GENETICS INC contract
FDA Milestone. The Committee's certification on or prior to the Expiration Date of the approval by the FDA for the commercial sale and marketing of rilonacept in the United States by the Company or any of the Company's partners for the treatment of recurrent pericarditis, based on the clinical trial data from the RHAPSODY Phase 3 clinical trial
All Definitions
